Activation of T cell checkpoint pathways during β‐cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes is a research paper published in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI073858
National Institutes of Health
Grant: R21AI069848
National Institutes of Health
Grant: R21AI133798
National Institutes of Health
Grant: 1R21AI133798-01
Contribution of Gut Symbiotic Bacteria to Autoimmunity
National Institutes of Health
Grant: 1R01AI073858-01A1
Dendritic cell directed T cell negative regulation for treating autoimmunity
National Institutes of Health
Grant: 1R21AI069848-01
Microsphere based Tolerogenic antigen presentation system
NIAID NIH HHS
Grant: R21 AI059745
FWCI
0.34
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals